Avidity Partners Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-215,100
Closed -$1.72M 88
2023
Q2
$1.72M Buy
+215,100
New +$1.59M 0.06% 89
2022
Q2
Sell
-1,694,700
Closed -$38.7M 86
2022
Q1
$38.7M Buy
+1,694,700
New +$41.4M 0.81% 37
2021
Q2
Sell
-1,891,300
Closed -$60M 120
2021
Q1
$60M Sell
1,891,300
-80,700
-4% -$2.37M 1.66% 20
2020
Q4
$41M Buy
+1,972,000
New +$36.8M 1.33% 26

Other funds holding BHC

Avidity Partners Management's BHC Position: Q3 2023 in Review

Avidity Partners Management sold out of Bausch Health (BHC) in Q3 2023, closing a stake of 215,100 shares — an estimated $1.72M sold.

Avidity Partners Management first reported a position in BHC in Q4 2020 and held it in 4 quarters. The position peaked at $60M in Q1 2021. 223 funds tracked by Wall St. Rank hold BHC as of Q3 2023.

  • Avidity Partners Management reported no remaining Bausch Health position as of Q3 2023 after selling out during the quarter.
  • Avidity Partners Management sold 215,100 Bausch Health shares in Q3 2023, an estimated $1.72M.
  • Avidity Partners Management first reported a position in Bausch Health in Q4 2020 and held it in 4 quarters.
  • Avidity Partners Management's Bausch Health position peaked at $60M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Bausch Health as of Q3 2023.

Based on Avidity Partners Management's 13F filing for Q3 2023, filed 14 Nov 2023.